Literature DB >> 989665

Anti-insulin-antibodies and late diabetic complications.

O O Andersen.   

Abstract

Two hundred and seventy-four insulin-dependent juvenile diabetics were examined. One hundred and sixty-six patients were without late diabetic complications, while 108 patients had one or more complications. At the time of the investigation patients with and without complications were found to have the same insulin requirement. Retrospectively it was observed, that after treatment for 10 years the insulin requirement was significantly higher among patients who had developed complications after treatment for 19 years as compared to patients who after 19 years of treatment had not developed complications. One hundred and eighty-four patients, of which 110 were without and 74 with late diabetic omplications were examined for anti-insulin-antibodies. Patients with complications, especially those with early onset of proliferative retinopathy or nephropathy had a slightly although insignificantly elevated plasma insulin-binding capacity. The frequency of high titres was significantly greater among patients with complications as compared to the frequency in patients without complications. The observations support the assumption, that insulin-anti-insulin-antibody complexes may aggravate the vascular complications.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 989665     DOI: 10.1530/acta.0.0830329

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  17 in total

1.  Phenotypes of the heavy chains of immunoglobulins in patients with diabetic microangiopathy: evidence for an immunogenetic predisposition.

Authors:  C Mijovic; J A Fletcher; A R Bradwell; A H Barnett
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-15

2.  A genetic study of retinopathy in south Indian type 2 (non-insulin-dependent) diabetic patients.

Authors:  K Hawrami; R Mohan; V Mohan; G A Hitman
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

Review 3.  Immunology in the early stages of type I diabetes.

Authors:  U Di Mario; P Pozzilli; D Andreani
Journal:  J Endocrinol Invest       Date:  1983-10       Impact factor: 4.256

4.  Prolonged disease-free survival in diabetics.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-25

Review 5.  Circulating immune complexes in diabetes.

Authors:  U Di Mario; M Iavicoli; D Andreani
Journal:  Diabetologia       Date:  1980-08       Impact factor: 10.122

6.  Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics.

Authors:  W J Irvine; S F Al-Khateeb; U Di Mario; C M Feek; R S Gray; B Edmond; L J Duncan
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

7.  Low plasma C4 concentrations: association with microangiopathy in insulin dependent diabetes.

Authors:  A H Barnett; C Mijovic; J Fletcher; I Chesner; B M Kulkuska-Langlands; R Holder; A R Bradwell
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-13

Review 8.  Insulin-dependent (type I) diabetes mellitus.

Authors:  W Rodger
Journal:  CMAJ       Date:  1991-11-15       Impact factor: 8.262

9.  Insulin antibodies and hypoglycemia in diabetic patients. Can a quantitative analysis of antibody binding predict the risk of hypoglycemia?

Authors:  M R Kim; L R Sheeler; N Mansharamani; M T Haug; C Faiman; M K Gupta
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

10.  Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study.

Authors:  A R Andersen; J S Christiansen; J K Andersen; S Kreiner; T Deckert
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.